STRASBOURG, France, December 18 /PRNewswire-FirstCall/ -- Transgene S.A. announces that it has assembled a Scientific Advisory Board (S.A.B.) comprising distinguished experts of international repute to advise the company with respect to research, clinical studies and regulatory matters. The Scientific Advisory Board, which held its first meeting today, includes the following members :
Brigitte Autran, M.D., Ph.D.
Brigitte Autran is coordinator of the Biomedical Investigations Center (Centre d'Investigations Biomedicales, CIB) at the Pitie-Salpetriere Hospital, Paris, France.
Jean-Yves Blay, M.D., Ph.D.
Jean-Yves Blay is Professor of Medical Oncology at the University Lyon I, Scientific Director of Canceropole Lyon Rhone-Alpes, France.
Pierre Chambon, Ph.D.
Pierre Chambon, honorary Professor at the College of France, is the founder and the honorary Director of the Institute of Genetics and Molecular and Cellular Biology (Institut de Genetique et de Biologie Moleculaire et Cellulaire, IGBMC) as well as the Mouse Clinic Institute (Institut Clinique de la Souris, ICS) in Strasbourg-Illkirch, France. He is currently the Director of the Strasbourg Alsace-Lorraine Genopole.
Pierre Coulie, Ph.D.
Pierre Coulie, Professor at the University of Louvain, (Brussels), Belgium, is a member of the Academy of Cancer Immunology and heads the Department of Genetics and Human Tumor Immunology.
Steven K. Dower, Ph.D.
Steven K. Dower, Professor at the University of Sheffield, UK, is a biochemist with a particular interest in the field of inflammation and innate immunity.
Philippe Kourilsky, Ph.D.
Philippe Kourilsky is Professor at the College de France and honorary General Director of the Pasteur Institute, Paris, France.
Rienk Offringa, Ph.D.
Rienk Offringa is Associate Professor and Head of the Tumor Immunology Group, Leiden University Medical Center, Leiden, The Netherlands.
Dennis L. Panicali, Ph.D.
Dennis L. Panicali, founded Therion Biologics Corporation in 1991 and served as President and CEO for 12 years.
Dana J. Philpott, Ph.D.
Dana J. Philpott is Assistant Professor at the Department of Immunology, University of Toronto, Ontario, Canada.
Monika M. Pietrek, M.D., Ph.D.
Monika M. Pietrek is Executive Vice President of Global Scientific and Medical Affairs at PRA International, Mannheim, Germany.
James Di Santo, M.D., Ph.D.
James Di Santo heads the Unit of Cytokines and Lymphoid Development at the Pasteur Institute, Paris, France.
Suzy M.E. Scholl, M.D.
Suzy M.E. Scholl's present activities include patient care in gynaecological and breast cancer, development of innovative gene therapy and vaccine trials. Suzy M.E. Scholl is a member of a Collaborative Interactive Project for vectored therapy, Paris, France.
Rafick-Pierre Sekaly, Ph.D.
Rafick-Pierre Sekaly is a full Professor at the University of Montreal. He holds the Canada chair in Human Immunology and is the Scientific Director and Program Leader of CANVAC.
Christopher Walker, Ph.D.
Christopher Walker is Director of the Center for Vaccines and Immunity at the Columbus Children's Research Institute, Colombus, Ohio, USA.
Jean-Claude Weill, Ph.D.
Jean-Claude Weill is Professor of Immunology at the Necker Hospital, Paris, France and Professor at the French University Institute (Institut Universitaire de France), Paris.
"We are very honoured to have assembled such renowned experts to form our Scientific Advisory Board", said Dr. Jean-Yves Bonnefoy, Vice President, Research and Development of Transgene. "Transgene's R&D leading activities in the field of immunotherapy of cancer and infectious diseases will benefit from the experience and insight of the SAB members".
About Transgene:
Transgene is a France-based biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases. The company has three compounds in Phase II trials and one compound in Phase I studies. Transgene has bio-manufacturing production capacities for viral-based vectors and technologies available for out-licensing. For further information about Transgene, please visit www.transgene.fr
Press Contacts: Transgene Capital MS&L Image 7 Philippe Poncet Mary Clark Estelle Guillot-Tantay +33-3-88-27-91-21 Halina Kukula Tiphaine Hecketsweiler +44-(0)20-7307-5330 +33-1-53-70-74-93
Transgene S.A.CONTACT: Press Contacts: Transgene ,Philippe Poncet, +33-3-88-27-91-21;Image 7, Estelle Guillot-Tantay, Tiphaine Hecketsweiler, +33-1-53-70-74-93;Capital MS&L, Mary Clark, Halina Kukula, +44-(0)20-7307-5330
